Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Hospital Practice (1995)|October 10, 2017
Evaluation of hospitalization costs and associated factors among maternity stays involving low-risk and moderate- to high-risk childbirths in the United StatesAmy Law, Justin Yu, Wenlong Lin, et al.
Contraception|October 6, 2014
Achieving cost-neutrality with long-acting reversible contraceptive methodsJames Trussell, Fareen Hassan, Julia Lowin, et al.
Contraception|April 24, 2018
Twelve-month discontinuation rates of levonorgestrel intrauterine system 13.5 mg and subdermal etonogestrel implant in women aged 18-44: A retrospective claims database analysisAmy Law, Laura Liao, Jay Lin, et al.
Mechanisms of Development|March 11, 2010
Tbx1 is necessary for palatal elongation and elevationSteven Goudy, Amy Law, Gabriela Sanchez, et al.
Current Medical Research and Opinion|December 28, 2012
Retrospective analysis of variation in heavy menstrual bleeding treatments by age and underlying causeRonda Copher, Elisabeth Le Nestour, Amy Law, et al.
Contraception|December 31, 2017
Long-term outcomes after elective sterilization procedures - a comparative retrospective cohort study of Medicaid patientsRachel Steward, Patricia Carney, Amy Law, et al.
The Journal of Infectious Diseases|December 22, 2023
Episodic Cost of Lower Respiratory Tract Illness due to Respiratory Syncytial Virus Among US Infants During the First Year of LifeAhuva Averin, Amy Law, Kimberly Shea, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neckAmy Law, Thomas Kennedy, Phillip Pellitteri, et al.
Hospital Pediatrics|June 12, 2023
Parent Preferences on Screening for Social Determinants of Health in Hospitalized ChildrenTamara Gayle, Amy Law, Stacey Stokes, et al.
Contraception|March 1, 2014
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraceptionJames Trussell, Fareen Hassan, Nathaniel Henry, et al.
Pageof 5